Cronos Group Inc. - Common Share (CRON): Price and Financial Metrics
GET POWR RATINGS... FREE!
CRON POWR Grades
- Sentiment is the dimension where CRON ranks best; there it ranks ahead of 48.35% of US stocks.
- CRON's strongest trending metric is Quality; it's been moving down over the last 48 weeks.
- CRON's current lowest rank is in the Quality metric (where it is better than 1.12% of US stocks).
CRON Stock Summary
- The ratio of debt to operating expenses for Cronos Group Inc is higher than it is for about just 8.93% of US stocks.
- With a price/sales ratio of 39.39, Cronos Group Inc has a higher such ratio than 93.93% of stocks in our set.
- Revenue growth over the past 12 months for Cronos Group Inc comes in at 81.99%, a number that bests 92.18% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Cronos Group Inc are XXII, TRUE, VCYT, DRQ, and FLNT.
- CRON's SEC filings can be seen here. And to visit Cronos Group Inc's official web site, go to www.thecronosgroup.com.
CRON Valuation Summary
- CRON's EV/EBIT ratio is -10; this is 134.13% lower than that of the median Healthcare stock.
- Over the past 43 months, CRON's price/sales ratio has gone down 2628.2.
- Over the past 43 months, CRON's price/sales ratio has gone down 2628.2.
Below are key valuation metrics over time for CRON.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| CRON | 2021-08-31 | 43.4 | 1.5 | -16.8 | -10.0 |
| CRON | 2021-08-30 | 42.1 | 1.5 | -16.3 | -9.5 |
| CRON | 2021-08-27 | 42.5 | 1.5 | -16.5 | -9.7 |
| CRON | 2021-08-26 | 42.1 | 1.5 | -16.3 | -9.5 |
| CRON | 2021-08-25 | 42.7 | 1.5 | -16.5 | -9.8 |
| CRON | 2021-08-24 | 43.3 | 1.5 | -16.7 | -10.0 |
CRON's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CRON has a Quality Grade of F, ranking ahead of 1.16% of graded US stocks.
- CRON's asset turnover comes in at 0.03 -- ranking 353rd of 677 Pharmaceutical Products stocks.
- 500 - Internal server error
The table below shows CRON's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.030 | -0.621 | -0.378 |
| 2021-03-31 | 0.027 | -0.439 | -0.870 |
| 2020-12-31 | 0.024 | -0.553 | -0.242 |
| 2020-09-30 | 0.019 | -0.749 | 0.191 |
| 2020-06-30 | 0.015 | -1.350 | 2.033 |
| 2020-03-31 | 0.014 | -1.185 | 6.271 |
CRON Price Target
For more insight on analysts targets of CRON, see our CRON price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $6.63 | Average Broker Recommendation | 2.36 (Moderate Sell) |
CRON Stock Price Chart Interactive Chart >
CRON Price/Volume Stats
| Current price | $5.70 | 52-week high | $15.83 |
| Prev. close | $6.00 | 52-week low | $4.91 |
| Day low | $5.68 | Volume | 2,225,200 |
| Day high | $5.97 | Avg. volume | 3,626,784 |
| 50-day MA | $6.63 | Dividend yield | N/A |
| 200-day MA | $8.51 | Market Cap | 2.13B |
Cronos Group Inc. - Common Share (CRON) Company Bio
Cronos Group seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations. The firm typically invests in companies based in Canada. Cronos Group was founded in January, 2013 and is based in Toronto, Canada.
Latest CRON News From Around the Web
Below are the latest news stories about Cronos Group Inc that investors may wish to consider to help them evaluate CRON as an investment opportunity.
Are Any Marijuana Stocks On U.S. Exchanges Good Buys Right Now After Aurora Lays Off More Staff?Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal. |
Top 10 Stocks to Invest in Based on Traci Lerner’s Chescapmanager LLC’s PortfolioIn this article, we discuss the top 10 stocks to invest in based on Traci Lerner’s Chescapmanager LLC’s portfolio. If you want to skip our detailed analysis of Traci Lerner’s history, investment philosophy, and hedge fund performance, go directly to the Top 5 Stocks to Invest In Based on Traci Lerner’s Chescapmanager LLC’s Portfolio. Price […] |
7 Top Robinhood Stocks to Buy Heading Into Q4These 7 Robinhood stocks are positioned for a rally in Q4 2021. |
3 Cannabis Stocks That Will Continue to Underperform the TSX in 2021 and BeyondHere''s why cannabis giants such as Aurora Cannabis and Cronos Group remain high-risk bets for long-term investors. The post 3 Cannabis Stocks That Will Continue to Underperform the TSX in 2021 and Beyond appeared first on The Motley Fool Canada . |
Cronos Stock: Primed for Rally after ConsolidationThe cannabis industry is going through interesting times. After a phase characterized by intense competition, the industry seems to be in a period of consolidation. Further, with increasing prospects of federal-level legalization of cannabis in the United States, there is the possibility of a big market opening up. Cronos (CRON) is one of the interesting plays in the cannabis industry. Its stock has largely been sideways year-to-date. (See Cronos stock charts on TipRanks) However, there continues to be positive business developments, and a rally seems likely. I am bullish on Cronos, considering industry tailwinds, and company-specific growth catalysts. |
CRON Price Returns
| 1-mo | -11.08% |
| 3-mo | -35.81% |
| 6-mo | -37.77% |
| 1-year | 12.20% |
| 3-year | -48.79% |
| 5-year | 820.84% |
| YTD | -17.87% |
| 2020 | -9.52% |
| 2019 | -26.18% |
| 2018 | 34.43% |
| 2017 | 600.87% |
| 2016 | N/A |
Continue Researching CRON
Here are a few links from around the web to help you further your research on Cronos Group Inc's stock as an investment opportunity:Cronos Group Inc (CRON) Stock Price | Nasdaq
Cronos Group Inc (CRON) Stock Quote, History and News - Yahoo Finance
Cronos Group Inc (CRON) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...